NIH-funded research Fellowship grant

Investigating the role of specific immune cells in high blood pressure

Official title: The Role of CCR10 and CCR10+ Tregs in Hypertension

Funded at Vanderbilt University · NIH-10998077 · Data updated 2026-11-12

This study is looking at how a special type of immune cell might affect high blood pressure, and it's for people with hypertension who want to help find new treatment options based on how the immune system works.

More Hypertension research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionVanderbilt University
NIH-funded
Lab location1 site (Nashville, UNITED STATES)
Project startDecember 1, 2024
Project endNovember 30, 2027
Funding year2024
Award (this year)$34,370
NIH project number1F31HL176154-01
Project IDNIH-10998077 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with hypertension, particularly those aged 21 and older.

Less likely to help

Patients with hypertension who do not have a significant immune component to their condition may not benefit from this research.

What this research studies

This research focuses on understanding how certain immune cells, particularly a subset known as CCR10+ regulatory T cells, influence high blood pressure (hypertension). By examining blood samples from individuals with hypertension and healthy controls, the study aims to identify differences in immune cell populations. The researchers will use advanced techniques to analyze these cells and explore their potential role in regulating blood pressure and associated health risks. Patients may benefit from insights that could lead to new treatments for hypertension based on immune system interactions.

Why it matters

Potential benefit: If successful, this research could lead to innovative therapies that better manage or even prevent hypertension by targeting immune cell functions.

How similar studies have gone: While the role of immune cells in hypertension is an emerging field, this specific investigation into CCR10+ Tregs is novel and has not been extensively tested in prior studies.

Where this research is happening

  • Vanderbilt University
    Nashville, United States
    Active

Researchers

  • Principal investigator: Nguyen, Bianca Alexandra — Vanderbilt University
  • Study coordinator: Nguyen, Bianca Alexandra

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.